Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin

Oral Oncology

Volumn 45, Issue 9, 2009, Pages

  Deng, Yi Ting ^a   Chen, Hsin Ming ^a   Cheng, Shih Jung ^a   Chiang, Chun Pin ^a   Kuo, Mark Yen Ping ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arecoline; CTGF; Curcumin; Oral submucous fibrosis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ALKALOID; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIOXIDANT; ARECOLINE; CONNECTIVE TISSUE GROWTH FACTOR; CURCUMIN; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BETEL NUT; CHEEK MUCOSA; CONCENTRATION RESPONSE; DRUG MECHANISM; ENDOTHELIUM CELL; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH DISEASE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; WESTERN BLOTTING;

ANTHRACENES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARECOLINE; CHEEK; CHOLINERGIC AGONISTS; CONNECTIVE TISSUE GROWTH FACTOR; CURCUMIN; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FIBROBLASTS; FLAVONOIDS; HUMANS; IMIDAZOLES; MOUTH MUCOSA; NITRILES; ORAL SUBMUCOUS FIBROSIS; PYRIDINES; SULFONES;

EID: 69249219162     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.04.004     Document Type: Article

References (31)

1. Rajalalitha P., and Vali S. Molecular pathogenesis of oral submucous fibrosis - a collagen metabolic disorder. J Oral Pathol Med 34 6 (2005) 321-328 [review]
2. Tilakaratne W.M., Klinikowski M.F., Saku T., Peters T.J., and Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42 6 (2006) 561-568 [review]
3. Harvey W., Scutt A., Meghji S., and Canniff J.P. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 31 1 (1986) 45-49
4. Yang S.F., Hsieh Y.S., Tsai C.H., Chou M.Y., and Chang Y.C. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39 4 (2003) 367-372
5. Tsai C.H., Chou M.Y., and Chang Y.C. The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 32 3 (2003) 146-153
6. Chang Y.C., Yang S.F., Tai K.W., Chou M.Y., and Hsieh Y.S. Increased tissue inhibitor metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38 2 (2002) 195-200
7. Shieh D.H., Chiang L.C., Lee C.H., Yang Y.H., and Shieh T.Y. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan. J Oral Pathol Med 33 9 (2004) 581-587
8. Scutt A., Meghji S., Canniff J.P., and Harvey W. Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia 43 4 (1987) 391-393
9. Shi-Wen X., Leask A., and Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth F R 19 2 (2008) 133-144 [review]
10. Leask A., Sa S., Holmes A., Shiwen X., Black C.M., and Abraham D.J. The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 54 3 (2001) 180-183
11. Allen J.T., Knight R.A., Bloor C.A., and Spiteri M.A. Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 21 6 (1999) 693-700
12. Paradis V., Dargere D., Vidaud M., De Gouville A.C., Huet S., Martinez V., et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30 4 (1999) 968-976
13. Ito Y., Aten J., Bende R.J., Oemar B.S., Rabelink T.J., Weening J.J., et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53 4 (1998) 853-861
14. Kantarci A., Black S., Xydas C., Murawel P., Uchida Y., Yucekal-Tuncer B., Atilla G., et al. Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol 210 1 (2006) 59-66
15. Mori T., Kawara S., Shinozaki M., Hayashi N., Kakinuma T., Igarashi A., et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 181 1 (1999) 153-159
16. Ikawa Y., Ng P.S., Endo K., Kondo M., Chujo S., Ishida W., et al. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis. J Cell Physiol 216 3 (2008) 680-687
17. Li G., Xie Q., Shi Y., Li D., Zhang M., Jiang S., et al. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 8 7 (2006) 889-900
18. Luo G.H., Lu Y.P., Song J., Yang L., Shi Y.J., and Li Y.P. Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy. Transplant P 40 7 (2008) 2365-2369
19. Duncan M.R., Frazier K.S., Abramson S., Williams S., Klapper H., Huang X., et al. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB J 13 13 (1999) 1774-1786
20. Utsunomiya H., Tilakaratne W.M., Oshiro K., Maruyama S., Suzuki M., Ida-Yonemochi H., et al. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med 34 8 (2005) 498-507
21. Chang HH, Chiang CP, Hung HC, Lin CY, Deng YT, Kuo MY. Histone deacetylase 2 expression predicts poorer prognosis in oral cancer patients. Oral Oncol, in press.
22. Ho T.J., Chiang C.P., Hong C.Y., Kok S.H., Kuo Y.S., and Kuo M.Y. Induction of the c-jun protooncogene expression by areca nut extract and arecoline on oral mucosal fibroblasts. Oral Oncol 36 5 (2000) 432-436
23. Lee J., Huang M.S., Yang I.C., Lai T.C., Wang J.L., Pang V.F., et al. Essential roles of caspases and their upstream regulators in rotenone-induced apoptosis. Biochem Biophys Res Commun 371 1 (2008) 33-38
24. Chang M.C., Wu H.L., Lee J.J., Lee P.H., Chang H.H., Hahn L.J., et al. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem 279 49 (2004) 50676-50683
25. Lin S.C., Lu S.Y., Lee S.Y., Lin C.Y., Chen C.H., and Chang K.W. Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int J Cancer 116 4 (2005) 526-535
26. Yang S.F., Tsai C.H., and Chang Y.C. The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline. J Oral Pathol Med 37 4 (2008) 206-210
27. Leask A., and Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J 18 7 (2004) 816-827
28. Denton C.P., Merkel P.A., Furst D.E., Khanna D., Emery P., Hsu V.M., et al. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 56 1 (2007) 323-333
29. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 82 1 (2002) 47-95 [review]
30. Goel A., Kunnumakkara A.B., and Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75 4 (2008) 787-809 [review]
31. Chen A., and Zheng S. Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signaling. Br J Pharmacol 153 3 (2008) 557-567